Comparing Obeticholic Acid vs Ursodiol
| Obeticholic acid | Ursodiol |
|
|---|
| Obeticholic acid | Ursodiol |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Primary Biliary Cholangitis. Obeticholic acid may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Primary Biliary Cholangitis, Nonalcoholic Steatohepatitis, Gallbladder Disease. Ursodiol may also be used for purposes not listed in this medication guide. |
Related suggestions Primary Biliary Cholangitis
|
|||||||
| More about Obeticholic acid | More about Ursodiol | ||||||||
| Ratings & Reviews | |||||||||
|
Obeticholic acid has an average rating of 7.3 out of 10 from a total of 3 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 0% reported a negative effect. |
Ursodiol has an average rating of 8.0 out of 10 from a total of 32 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 13% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
|
View all Obeticholic acid side effects |
View all Ursodiol side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
Lower cost generic |
||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Ursodiol prices |
||||||||
| Dosage Forms | |||||||||
|
N/A |
|
||||||||
| Brand Names | |||||||||
| Ocaliva | Actigall, Reltone, Urso, Urso Forte | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
N/A |
139.2 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 64 drugs are known to interact with Obeticholic acid:
|
A total of 7 drugs are known to interact with Ursodiol:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
May 27, 2016 |
December 31, 1987 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Livdelzi
Livdelzi (seladelpar) is an oral prescription medicine that may be used to treat primary biliary ...
Elafibranor
Elafibranor is used to treat primary biliary cholangitis (PBC) in combination with ursodeoxycholic a ...
Ocaliva
Ocaliva may be used to treat primary biliary cholangitis (PBC) in adults without cirrhosis or with ...
Actigall
Actigall is used for gallbladder disease, primary biliary cholangitis
Iqirvo
Iqirvo (elafibranor) is used to treat primary biliary cholangitis (PBC) in combination with ...
Urso Forte
Urso Forte is used for gallbladder disease, primary biliary cholangitis
Elafibranor
Elafibranor is used to treat primary biliary cholangitis (PBC) in combination with ursodeoxycholic a ...
Seladelpar
Seladelpar is used to treat primary biliary cholangitis (PBC) in adults in combination with ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.